Noot bij HvJ, 12 september 2024, C-248/23, Novo Nordisk (Door Hongaarse wetgeving opgelegde betalingen kwalificeren als prijsvermindering)

Research output: Contribution to journalCase noteProfessional

Original languageDutch
JournalNLFiscaal
Volume2024
Issue number2228
Publication statusPublished - 8 Oct 2024

Court cases

CourtHof van Justitie EU
Date of judgement12/09/24
ECLI IDECLI:EU:C:2024:735
Case numberC-248/23

Cite this